Skip to main content
Top
Published in: Diabetologia 8/2004

01-08-2004 | Article

Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up

Authors: J. Plank, G. Köhler, I. Rakovac, B. M. Semlitsch, K. Horvath, G. Bock, B. Kraly, T. R. Pieber

Published in: Diabetologia | Issue 8/2004

Login to get access

Abstract

Aims/hypothesis

This study was conducted to evaluate the long-term outcome of a structured outpatient diabetes teaching and treatment programme (DTTP) for intensified insulin therapy in patients with Type 1 diabetes, which aims to improve metabolic control without increasing the risk of severe hypoglycaemia.

Methods

All 123 diabetic outpatients (age 41±14 years; 64 women; BMI 23.5±3.1; diabetes duration 17±11 years; HbA1c 7.9±1.6%; 32 patients with a history of severe hypoglycaemia; 18 with overt nephropathy; 22 with proliferative retinopathy) who participated in the DTTP between June 1989 and June 1990 were invited for follow-up visits after 3, 6 and 12 years.

Results

Out of the 123 patients, 11 died during the follow-up period, two were lost for follow-up, and one was not willing to participate in re-evaluation after 12 years. Mean HbA1c levels decreased from 7.9±1.6% to 7.1±1.2% (p<0.01) after 3 years, and were 7.8±1.5% (NS) and 7.8±1.2% (NS) after 6 and 12 years respectively. Frequency of hypoglycaemia decreased from 0.49 episodes per patient per year to 0.14 after 3 years (p<0.01), 0.19 after 6 years (p<0.01) and 0.16 after 12 years (p<0.01). Of the participants, 41% were able to lower HbA1c levels without episodes of severe hypoglycaemia and to maintain this improvement at all follow-up visits over the 12-year period. At follow-up, intensified insulin therapy was carried out by 94% of the patients.

Conclusions/interpretation

A sustained reduction of the incidence of severe hypoglycaemia was observed in patients with Type 1 diabetes after participation in a structured outpatient DTTP over a 12-year period.
Literature
1.
go back to reference Bradley C, Speight J (2002) Patients perceptions of diabetes and diabetes therapy: assessing quality of life. Diabet Metab Res Rev 18 [Suppl 3]:64–69 Bradley C, Speight J (2002) Patients perceptions of diabetes and diabetes therapy: assessing quality of life. Diabet Metab Res Rev 18 [Suppl 3]:64–69
2.
go back to reference The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRefPubMed The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRefPubMed
3.
go back to reference The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of Type 1 diabetes mellitus. JAMA 287:2563–2569PubMed The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of Type 1 diabetes mellitus. JAMA 287:2563–2569PubMed
4.
go back to reference The DCCT Research Group (1997) Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271–286PubMed The DCCT Research Group (1997) Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46:271–286PubMed
5.
go back to reference Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ (1995) Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18:625–630PubMed Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ (1995) Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care 18:625–630PubMed
6.
go back to reference Bott S, Bott U, Berger M, Mühlhauser I (1997) Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 40:926–932CrossRefPubMed Bott S, Bott U, Berger M, Mühlhauser I (1997) Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 40:926–932CrossRefPubMed
7.
go back to reference DAFNE Study Group (2002) Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 325:746–751CrossRefPubMed DAFNE Study Group (2002) Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 325:746–751CrossRefPubMed
8.
go back to reference Semlitsch B, Goritschan D, Zapotoczky H, Brunner GA, Siebenhofer A, Pieber TR (1997) Long term effect of a structured outpatient education programme in IDDM—a 6 year follow-up. Diabetologia 40:A609 (Abstract) Semlitsch B, Goritschan D, Zapotoczky H, Brunner GA, Siebenhofer A, Pieber TR (1997) Long term effect of a structured outpatient education programme in IDDM—a 6 year follow-up. Diabetologia 40:A609 (Abstract)
9.
go back to reference Mühlhauser I, Jörgens V, Berger M et al. (1983) Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25:470–476PubMed Mühlhauser I, Jörgens V, Berger M et al. (1983) Bicentric evaluation of a teaching and treatment programme for Type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 25:470–476PubMed
10.
go back to reference Mühlhauser I, Bruckner I, Berger M et al. (1987) Evaluation of an intensified insulin treatment programme as routine management of Type 1 (insulin-dependent) diabetes: the Bucharest-Düsseldorf Study. Diabetologia 30:681–690PubMed Mühlhauser I, Bruckner I, Berger M et al. (1987) Evaluation of an intensified insulin treatment programme as routine management of Type 1 (insulin-dependent) diabetes: the Bucharest-Düsseldorf Study. Diabetologia 30:681–690PubMed
11.
go back to reference Mühlhauser I, Berger M (2002) Patient education—evaluation of a complex intervention. Diabetologia 45:1723–1733CrossRefPubMed Mühlhauser I, Berger M (2002) Patient education—evaluation of a complex intervention. Diabetologia 45:1723–1733CrossRefPubMed
12.
go back to reference Halwachs-Baumann G, Katzensteiner S, Schnedl W, Pürstner P, Pieber TR, Wilders-Truschnig M (1997) Comparative evaluation of three assay systems for automated determination of hemoglobin A1c. Clinical Chemistry 43:511–517PubMed Halwachs-Baumann G, Katzensteiner S, Schnedl W, Pürstner P, Pieber TR, Wilders-Truschnig M (1997) Comparative evaluation of three assay systems for automated determination of hemoglobin A1c. Clinical Chemistry 43:511–517PubMed
13.
go back to reference Hardin JW, Hilbe JM (2003) Generalized estimating equations. Chapman & HALL/CRC, London Hardin JW, Hilbe JM (2003) Generalized estimating equations. Chapman & HALL/CRC, London
14.
go back to reference Ihaka R, Gentleman DR (1996) A language for data analysis and graphics. J Comput Graph Stat 5:299–314 Ihaka R, Gentleman DR (1996) A language for data analysis and graphics. J Comput Graph Stat 5:299–314
15.
go back to reference Mühlhauser I, Sawicki PT, Blank M, Overmann H, Bender R, Berger M (2000) Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy. J Int Med 248:333–341CrossRef Mühlhauser I, Sawicki PT, Blank M, Overmann H, Bender R, Berger M (2000) Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy. J Int Med 248:333–341CrossRef
16.
go back to reference Mühlhauser I, Overmann H, Bender R, Jörgens V, Berger M (2000) Predictor of mortality and endstage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. Diabet Med 17:727–734CrossRefPubMed Mühlhauser I, Overmann H, Bender R, Jörgens V, Berger M (2000) Predictor of mortality and endstage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. Diabet Med 17:727–734CrossRefPubMed
17.
go back to reference Bragd J, Adamson U, Lins PE, Wredling R, Oskarsson P (2003) A repeated cross-sectional survey of severe hypoglycaemia in 178 Type 1 diabetes mellitus patients performed in 1984 and 1998. Diabet Med 20:216–219PubMed Bragd J, Adamson U, Lins PE, Wredling R, Oskarsson P (2003) A repeated cross-sectional survey of severe hypoglycaemia in 178 Type 1 diabetes mellitus patients performed in 1984 and 1998. Diabet Med 20:216–219PubMed
18.
go back to reference Reichard P, Nilsson BY, Rosenquist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309CrossRefPubMed Reichard P, Nilsson BY, Rosenquist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304–309CrossRefPubMed
19.
go back to reference Marrero DG, Guare JC, Vandagriff JL, Fineberg NS (1997) Fear of hypoglycemia in the parents of children and adolescents with diabetes: maladaptive or healthy response? Diabetes Educ 23:281–286PubMed Marrero DG, Guare JC, Vandagriff JL, Fineberg NS (1997) Fear of hypoglycemia in the parents of children and adolescents with diabetes: maladaptive or healthy response? Diabetes Educ 23:281–286PubMed
20.
go back to reference Rubin RR, Peyrot M (1992) Psycholosocial problems and interventions in diabetes: a review of the literature. Diabetes Care 15:1640–1657PubMed Rubin RR, Peyrot M (1992) Psycholosocial problems and interventions in diabetes: a review of the literature. Diabetes Care 15:1640–1657PubMed
21.
go back to reference Cox DJ, Gonder-Frederick L (1992) Major developments in behavioural diabetes research. J Consult Clin Psychol 60:628–638CrossRefPubMed Cox DJ, Gonder-Frederick L (1992) Major developments in behavioural diabetes research. J Consult Clin Psychol 60:628–638CrossRefPubMed
22.
go back to reference Bott U, Jörgens V, Grüsser M, Bender R, Mühlhauser I, Berger M (1994) Predictors of glycaemic control in Type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 11:362–171PubMed Bott U, Jörgens V, Grüsser M, Bender R, Mühlhauser I, Berger M (1994) Predictors of glycaemic control in Type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med 11:362–171PubMed
23.
go back to reference Hampson SE, Skinner TC, Hart J et al. (2000) Behavioral interventions for adolescents with type 1 diabetes. Diabetes Care 23:1416–1422PubMed Hampson SE, Skinner TC, Hart J et al. (2000) Behavioral interventions for adolescents with type 1 diabetes. Diabetes Care 23:1416–1422PubMed
24.
go back to reference Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Galli MA (2004) Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 47:622–629CrossRef Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Galli MA (2004) Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 47:622–629CrossRef
25.
go back to reference Garg SK, Schwartz S, Edelman SV (2004) Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 27:734–738PubMed Garg SK, Schwartz S, Edelman SV (2004) Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 27:734–738PubMed
26.
go back to reference Robertson RP (2004) Islet transplantation as a treatment for diabetes—a work in progress. N Engl J Med 350:694–705CrossRefPubMed Robertson RP (2004) Islet transplantation as a treatment for diabetes—a work in progress. N Engl J Med 350:694–705CrossRefPubMed
27.
go back to reference Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590–596PubMed Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590–596PubMed
28.
go back to reference Tuomilehto J, Borch-Johnsen K, Molarius A (1998) Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 41:784–790CrossRefPubMed Tuomilehto J, Borch-Johnsen K, Molarius A (1998) Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 41:784–790CrossRefPubMed
Metadata
Title
Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up
Authors
J. Plank
G. Köhler
I. Rakovac
B. M. Semlitsch
K. Horvath
G. Bock
B. Kraly
T. R. Pieber
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1456-x

Other articles of this Issue 8/2004

Diabetologia 8/2004 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.